#diabetes_treatment

Thiard News@F4F

@newsen.bsky.social

1 week ago

Morphic Medical Welcomes Veteran Health Leader Terri Cooper to Its Board Morphic Medical, creator of a pioneering diabetes treatment device, announces the appointment of healthcare veteran Terri Cooper to its board.

Morphic Medical Welcomes Veteran Health Leader Terri Cooper to Its Board #USA #Boston #diabetes_treatment #Morphic_Medical #Terri_Cooper

Thiard News@F4F

@newsen.bsky.social

3 months ago

Avant Technologies Revolutionizes Diabetes Treatment with Cell Encapsulation Technology Innovations Avant Technologies partners with SGAustria to enhance diabetes treatment using cell encapsulation technology, aimed at transforming patient care worldwide.

Avant Technologies Revolutionizes Diabetes Treatment with Cell Encapsulation Technology Innovations #USA #Las_Vegas #Avant_Technologies #diabetes_treatment #Cell_Encapsulation

Thiard News@F4F

@newsen.bsky.social

5 months ago

Aqua Medical Advances Diabetes Treatment with FDA IDE Approval for Innovative Endoscopic Procedure Aqua Medical has received FDA IDE approval for its Proximal Intestinal Mucosal Ablation procedure, marking a new era in diabetes treatment with its minimally invasive method.

Aqua Medical Advances Diabetes Treatment with FDA IDE Approval for Innovative Endoscopic Procedure #United_States #Pleasanton #diabetes_treatment #Aqua_Medical #PIMA

Thiard News@F4F

@newsen.bsky.social

5 months ago

Visionary Holdings Partners to Revolutionize Diabetes Treatment with Stem Cell Technology Visionary Holdings has secured a global license for innovative stem cell technology aimed at advancing diabetes treatment, offering potential long-term remission.

Visionary Holdings Partners to Revolutionize Diabetes Treatment with Stem Cell Technology #Canada #Toronto #Stem_Cell_Technology #diabetes_treatment #Visionary_Holdings

Thiard News@F4F

@newsen.bsky.social

7 months ago

Twin Health Secures $53 Million Investment to Enhance AI for Diabetes and Obesity Solutions Twin Health, a leader in AI for metabolic health, announces a $53 million investment aimed at transforming diabetes and obesity treatments while minimizing medication reliance.

Twin Health Secures $53 Million Investment to Enhance AI for Diabetes and Obesity Solutions #United_States #Mountain_View #diabetes_treatment #Twin_Health #AI_Digital_Twin

Thiard News@F4F

@newsen.bsky.social

7 months ago

CVCO Therapeutics Partners with Karolinska University to Explore Microvascular Dysfunction Treatment CVCO Therapeutics and Karolinska University Hospital have joined forces to advance treatments for microvascular dysfunction in diabetes patients.

CVCO Therapeutics Partners with Karolinska University to Explore Microvascular Dysfunction Treatment #USA #San_Diego #diabetes_treatment #CVCO_Therapeutics #Karolinska_University

Thiard News@F4F

@newsen.bsky.social

9 months ago

Breakthrough in Diabetes Treatment: Scientists 3D Print Functional Human Islets A pioneering team of scientists has achieved a remarkable breakthrough in type 1 diabetes treatment by successfully 3D printing functional human islets, marking a potential shift in diabetes management.

Breakthrough in Diabetes Treatment: Scientists 3D Print Functional Human Islets #London #United_Kingdom #3D_Printing #diabetes_treatment #Human_Islets

Thiard News@F4F

@newsen.bsky.social

9 months ago

Breakthrough in Diabetes Treatment with 3D Printed Human Islets at ESOT 2025 Congress Scientists reveal a revolutionary method for treating type 1 diabetes by 3D printing functional human islets, discussed at the ESOT 2025 congress.

Breakthrough in Diabetes Treatment with 3D Printed Human Islets at ESOT 2025 Congress #USA #London #3D_Printing #diabetes_treatment #ESOT_Congress

Thiard News@F4F

@newsen.bsky.social

9 months ago

BrightGene Unveils Promising Phase 2 Data on Its Dual Agonist for Weight Management and Type 2 Diabetes BrightGene Pharmaceutical Company presents significant Phase 2 findings for its dual GLP-1R/GIPR agonist aimed at tackling weight management and Type 2 diabetes, showcasing potential advancements in treatment options.

BrightGene Unveils Promising Phase 2 Data on Its Dual Agonist for Weight Management and Type 2 Diabetes #China #Suzhou #diabetes_treatment #BrightGene #BGM0504

Thiard News@F4F

@newsen.bsky.social

9 months ago

Eli Lilly's Once-Weekly Insulin Efsitora Alfa: A Game Changer in Diabetes Management Eli Lilly's revolutionary once-weekly insulin efsitora alfa demonstrates safe and effective management for Type 2 diabetes, presenting major advancements over traditional dosing.

Eli Lilly's Once-Weekly Insulin Efsitora Alfa: A Game Changer in Diabetes Management #United_States #Indianapolis #Eli_Lilly #diabetes_treatment #Insulin_Efsitora

Thiard News@F4F

@newsen.bsky.social

9 months ago

Neodyne Biosciences' Embrace Patch: A Breakthrough for Lipohypertrophy in Diabetes Care Neodyne Biosciences unveils the embrace Active Site Care patch, significantly improving lipohypertrophy in insulin-dependent diabetes patients. Discover its groundbreaking results.

Neodyne Biosciences' Embrace Patch: A Breakthrough for Lipohypertrophy in Diabetes Care #USA #Chicago #diabetes_treatment #Neodyne_Biosciences #Lipohypertrophy

Thiard News@F4F

@newsen.bsky.social

11 months ago

RedHill Biopharma's Opaganib Shows Promise in Weight Loss and Diabetes, Potentially Disrupting $100B Market RedHill Biopharma has published positive data on Opaganib in treating obesity and diabetes, indicating its potential to disrupt the $100 billion market.

RedHill Biopharma's Opaganib Shows Promise in Weight Loss and Diabetes, Potentially Disrupting $100B Market #Raleigh #Israel #RedHill_Biopharma #Opaganib #diabetes_treatment

Thiard News@F4F

@newsen.bsky.social

1 year ago

NLS Pharmaceutics and Kadimastem Collaborate to Revolutionize Diabetes Management with Innovative Multi-Target Solutions NLS Pharmaceutics and Kadimastem are set to change diabetes treatment with their unique approach, moving beyond traditional therapies for better patient outcomes.

NLS Pharmaceutics and Kadimastem Collaborate to Revolutionize Diabetes Management with Innovative Multi-Target Solutions #Switzerland #NLS_Pharmaceutics #Zurich #Kadimastem #diabetes_treatment